IL320332A - שיטות לטיפול בסרטן - Google Patents
שיטות לטיפול בסרטןInfo
- Publication number
- IL320332A IL320332A IL320332A IL32033225A IL320332A IL 320332 A IL320332 A IL 320332A IL 320332 A IL320332 A IL 320332A IL 32033225 A IL32033225 A IL 32033225A IL 320332 A IL320332 A IL 320332A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- treating cancer
- cancer
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263418089P | 2022-10-21 | 2022-10-21 | |
| US202363443877P | 2023-02-07 | 2023-02-07 | |
| US202363469252P | 2023-05-26 | 2023-05-26 | |
| PCT/US2023/077441 WO2024086809A1 (en) | 2022-10-21 | 2023-10-20 | Methods for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL320332A true IL320332A (he) | 2025-06-01 |
Family
ID=88874777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL320332A IL320332A (he) | 2022-10-21 | 2023-10-20 | שיטות לטיפול בסרטן |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4605392A1 (he) |
| JP (1) | JP2025538097A (he) |
| KR (1) | KR20250110370A (he) |
| CN (1) | CN120418247A (he) |
| AU (1) | AU2023364551A1 (he) |
| CL (1) | CL2025001163A1 (he) |
| IL (1) | IL320332A (he) |
| MX (1) | MX2025004532A (he) |
| TW (1) | TW202421628A (he) |
| WO (1) | WO2024086809A1 (he) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202303419D0 (en) * | 2023-03-08 | 2023-04-19 | Otsuka Pharma Co Ltd | Compounds |
| WO2025077778A1 (zh) * | 2023-10-12 | 2025-04-17 | 上海宇道生物技术有限公司 | 一类羧酸类化合物及其制备方法和应用 |
| WO2025011684A2 (zh) * | 2023-10-20 | 2025-01-16 | 上海宇道生物技术有限公司 | 一类n-磺酰酰胺含氮稠杂环类化合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018055316A1 (fr) * | 2016-09-26 | 2018-03-29 | Centre National De La Recherche Scientifique | Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives |
| WO2022213975A1 (en) * | 2021-04-08 | 2022-10-13 | Jacobio Pharmaceuticals Co., Ltd. | Compounds targeting y220c mutant of p53 |
-
2023
- 2023-10-20 TW TW112140291A patent/TW202421628A/zh unknown
- 2023-10-20 WO PCT/US2023/077441 patent/WO2024086809A1/en not_active Ceased
- 2023-10-20 JP JP2025523024A patent/JP2025538097A/ja active Pending
- 2023-10-20 AU AU2023364551A patent/AU2023364551A1/en active Pending
- 2023-10-20 CN CN202380088588.8A patent/CN120418247A/zh active Pending
- 2023-10-20 EP EP23809862.8A patent/EP4605392A1/en active Pending
- 2023-10-20 IL IL320332A patent/IL320332A/he unknown
- 2023-10-20 KR KR1020257016596A patent/KR20250110370A/ko active Pending
-
2025
- 2025-04-16 MX MX2025004532A patent/MX2025004532A/es unknown
- 2025-04-17 CL CL2025001163A patent/CL2025001163A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202421628A (zh) | 2024-06-01 |
| AU2023364551A1 (en) | 2025-05-08 |
| WO2024086809A1 (en) | 2024-04-25 |
| CL2025001163A1 (es) | 2025-10-03 |
| KR20250110370A (ko) | 2025-07-18 |
| MX2025004532A (es) | 2025-07-01 |
| CN120418247A (zh) | 2025-08-01 |
| EP4605392A1 (en) | 2025-08-27 |
| JP2025538097A (ja) | 2025-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL304275A (he) | שיטות לטיפול בסרטן | |
| IL312680A (he) | שיטות לטיפול בסרטן | |
| IL287907A (he) | שיטות לטיפול בסרטן | |
| IL320332A (he) | שיטות לטיפול בסרטן | |
| PT4225297T (pt) | Terapia de combinação para o tratamento de cancro | |
| ZA202310076B (en) | Combination therapies for treating cancer | |
| IL289811A (he) | שיטה לטיפול בסרטן | |
| IL319513A (he) | תרכובות לטיפול בסרטן | |
| PL4048284T4 (pl) | Metoda leczenia nowotworów | |
| AU2024225706A1 (en) | Methods for treating breast cancer | |
| CA3262155A1 (en) | COMPOUNDS FOR CANCER TREATMENT | |
| CA3254949A1 (en) | Polytherapy for the treatment of cancer | |
| IL320471A (he) | שיטות לטיפול בסרטן המבטא dll3 | |
| IL305974A (he) | שילובים רוקחיים לטיפול בסרטן | |
| IL317472A (he) | ארבציקלין לטיפול בסרטן | |
| GB202412414D0 (en) | Methods for treating cancer | |
| GB201909466D0 (en) | Compounds for treating cancer | |
| HK40109687A (en) | Methods for treating cancer | |
| GB202300668D0 (en) | Cancer treating compounds | |
| HK40095092A (en) | Methods for treating cancer | |
| IL317573A (he) | טיפול משולב לטיפול בסרטן | |
| IL316016A (he) | טיפול משולב לטיפול בסרטן | |
| IL316019A (he) | טיפול משולב לטיפול בסרטן | |
| GB201910244D0 (en) | Method for treating cancer | |
| CA3252465A1 (en) | CANCER TREATMENT |